CVRdatabase
Menu

Nordic Bioscience A/S

Public limited companyCVR 30799968HerlevActive

Nordic Bioscience A/S is a public limited company, based in Herlev, active in research and experimental development on natural sciences and engineering, founded in 2007. Net profit rose 23% from 2024 to 2025, ending at DKK 96.5m. Measured by gross profit, it ranks no. 10 of 421 companies in the industry in the database. Profit has grown three years in a row.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 379.3m+16.8% vs. 2024
Net profitDKK 96.5m+23.2% vs. 2024
EquityDKK 131.2m+17.9% vs. 2024
Employees206latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 11% (2024 → 2025), to DKK 292.1m.
  • Revenue rose 17% (2024 → 2025), to DKK 379.3m.
  • Net profit rose 23% (2024 → 2025), to DKK 96.5m.
  • Equity rose 18% (2024 → 2025), to DKK 131.2m.

Employees

  • 12 more employees than a year earlier: 206 (07/2026) against 194 (07/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100mDKK 120mDKK 140m202020212022202320242025
EquityNet profit
Financial figures for Nordic Bioscience A/S
202020212022202320242025Change
Revenuenot stated271,014313,570236,409324,920379,345+16.8%
Gross profit254,960239,141263,246180,286263,400292,105+10.9%
Operating profit (EBIT)114,038128,715139,79033,09697,108126,480+30.2%
Profit before tax112,156127,490138,10843,008101,600125,913+23.9%
Net profit93,354104,796113,23433,66478,38896,537+23.2%
Total assets255,699265,898271,867291,155425,370483,363+13.6%
Equity113,378117,73171,66761,597111,251131,205+17.9%
Liabilities141,726147,346197,251226,299312,895352,050+12.5%
Cash and cash equivalents18,90159,46057,59766,10288,51920,674−76.6%
Average number of employees136150167171176179+1.7%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 50mDKK 100mDKK 150mDKK 200mDKK 250mDKK 300m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Nordic Bioscience A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202517/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202409/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202308/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202230/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202110/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202005/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
05010015020008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 292.1mNo. 10 of 421
Better than 98% of the companies in the industry
EquityDKK 131.2mNo. 30 of 431
Better than 93% of the companies in the industry
Number of employees206No. 11 of 431
Better than 98% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 200–499 employees796 companies in the comparison
No. 153of 763
Better than 80%
No. 341of 796
Better than 57%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 205of 24,791
Better than 99%
No. 1,087of 24,909
Better than 96%
All companies of type A/S18,025 companies in the comparison
No. 526of 17,786
Better than 97%
No. 1,898of 18,024
Better than 89%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Nordic Bioscience A/SDKK 292.1m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Nordic Bioscience A/SDKK 96.5m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Nordic Bioscience A/SDKK 131.2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Nordic Bioscience A/S206
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Nordic Bioscience Holding A/S100%
Nordic Bioscience A/S

Management

4 active registrations

Executive management

Executive management at Nordic Bioscience A/S
NameRoleAppointed
Morten Asser KarsdalDirector15/10/2010

Board of directors

Board of directors at Nordic Bioscience A/S
NameRoleAppointed
Claus Henrik ChristiansenBoard member13/08/2007
Thomas NielsenBoard member13/08/2007
Bente Juel ChristiansenBoard member15/10/2010
Former management (3)
Former management at Nordic Bioscience A/S
NameRoleAppointedResigned
Claus Henrik ChristiansenDirector13/08/200722/12/2008
Morten Asser KarsdalBoard member13/08/200715/10/2010
Peter Degnboel ThostrupDirector22/12/200815/10/2010

Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening, af et medlem af bestyrelsen og en direktør i forening eller af den samlede bestyrelse.

Address and production units

1 active production units

Herlev Hovedgade 205
2730 Herlev

Herlev Municipality · Postcode 2730

Other companies at the address (1)

Open in OpenStreetMap
Production units
Production unitAddressEmployeesP number
NORDIC BIOSCIENCE A/SHerlev Hovedgade 205, 2730 Herlev2121013533160

Purpose

Selskabets formål er at drive virksomhed indenfor bioteknologi og anden dermed i forbindelse stående virksomhed, herunder at eje datterselskaber og kapitalandele i forbindelse hermed.

The purpose is quoted from the register in Danish.

Changes year by year

27 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20181 changeaddress 1
  • Moved to Herlev Hovedgade 205, 2730 Herlev
20161 changeaddress 1
  • Moved to Herlev Hovedgade 205-207, 2730 Herlev
20131 changeindustry 1
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20121 changemerger 1
  • Merger registered in CVR
20111 changeindustry 1
  • Industry changed to Activities of non-financial head offices (701010)
20104 changesmanagement 4
  • Bente Juel Christiansen appointed board member
  • Morten Asser Karsdal appointed director
  • Peter Degnboel Thostrup stepped down as director
  • Morten Asser Karsdal stepped down as board member
20083 changesmanagement 2 · industry 1
  • Peter Degnboel Thostrup appointed director
  • Claus Henrik Christiansen stepped down as director
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20078 changesaddress 1 · industry 1 · founded 1 · management 4 · ownership 1
  • Moved to Herlev Hovedgade 207, 2730 Herlev
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
  • Registered as NORDIC BIOSCIENCE A/S
  • Thomas Nielsen appointed board member
  • Claus Henrik Christiansen appointed board member
  • Morten Asser Karsdal appointed board member
  • Claus Henrik Christiansen appointed director
  • NORDIC BIOSCIENCE HOLDING A/S registered as owner (100%)

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction